PTC Therapeutics (PTCT) Buy Rating Maintained at Deutsche Bank
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 60.88 +0.91 (1.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.97 | 52 Week High | $35.40 | |||
| Open | $61.05 | 52 Week Low | $4.03 | |||
| Day High | $62.16 | P/E | 6.48 | |||
| Day Low | $59.16 | EPS | $9.40 | |||
| Volume | 1,339,274 | |||||
